ROYAL BANK OF CANADA - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 28 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q3 2016$3,000
-87.5%
5,000
-58.3%
0.00%
Q2 2016$24,000
-57.9%
12,000
-48.9%
0.00%
Q1 2016$57,000
-68.3%
23,4920.0%0.00%
Q4 2015$180,000
+38.5%
23,492
-4.1%
0.00%
Q3 2015$130,000
-43.5%
24,502
-4.7%
0.00%
Q2 2015$230,000
+23.7%
25,702
-12.6%
0.00%
Q1 2015$186,000
-4.6%
29,392
-12.0%
0.00%
Q4 2014$195,000
-17.4%
33,392
-2.9%
0.00%
Q3 2014$236,000
-32.0%
34,400
+42.1%
0.00%
Q2 2014$347,000
+69.3%
24,214
+22.9%
0.00%
Q1 2014$205,00019,7000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q4 2014
NameSharesValueWeighting ↓
Opaleye Management Inc. 565,000$4,334,0001.81%
Ghost Tree Capital, LLC 350,000$2,685,0001.10%
Avoro Capital Advisors LLC 340,300$2,610,0000.90%
PURA VIDA INVESTMENTS, LLC 217,900$1,671,0000.70%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,467,858$11,258,0000.55%
Broadfin Capital, LLC 890,748$6,832,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,315,551$10,090,0000.41%
Lombard Odier Asset Management (USA) Corp 348,641$2,674,0000.26%
TURNER INVESTMENTS LLC 122,000$936,0000.19%
Integre Asset Management, LLC 64,317$493,0000.12%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders